+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

LAMEA Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • January 2024
  • 109 Pages
  • Africa, Middle East
From
Europe Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • January 2024
  • 108 Pages
  • Europe
From
Asia Pacific Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • January 2024
  • 109 Pages
  • Asia Pacific
From
Bipolar Depression - Pipeline Insight, 2025 - Product Thumbnail Image

Bipolar Depression - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
High Potency Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Product (Synthetic, Biotech), By Manufacturer Type (In-house), By Drug Type, By Application, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

High Potency Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Product (Synthetic, Biotech), By Manufacturer Type (In-house), By Drug Type, By Application, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • March 2023
  • 191 Pages
  • Global
From
PD-1 & PD-L1 Inhibitors Market by Product Type (PD-1 Inhibitor, PD-L1 Inhibitor), Indication (Bladder Cancer, Head and Neck Cancer, Lung Cancer), End User, Distribution Channel, Route Of Administration, Company - Global Forecast 2025-2030 - Product Thumbnail Image

PD-1 & PD-L1 Inhibitors Market by Product Type (PD-1 Inhibitor, PD-L1 Inhibitor), Indication (Bladder Cancer, Head and Neck Cancer, Lung Cancer), End User, Distribution Channel, Route Of Administration, Company - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Biopharmaceuticals - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Thumbnail Image

Biopharmaceuticals - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • July 2024
  • 208 Pages
  • Global
From
NAMPT Inhibitors Market, Distribution by Type of Molecule, Therapeutic Area, Indication, Route of Administration, Line of Treatment, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2040 - Product Thumbnail Image

NAMPT Inhibitors Market, Distribution by Type of Molecule, Therapeutic Area, Indication, Route of Administration, Line of Treatment, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2040

  • Report
  • September 2022
  • 141 Pages
  • Global
From
Acute Lymphoblastic Leukemia Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Acute Lymphoblastic Leukemia Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • October 2023
  • 104 Pages
  • Global
From
Autoimmune Disease Therapeutics Market by Therapeutic Types, Disease Type, Route of Administration, Therapeutic Application, End-User - Global Forecast 2025-2030 - Product Thumbnail Image

Autoimmune Disease Therapeutics Market by Therapeutic Types, Disease Type, Route of Administration, Therapeutic Application, End-User - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
Next Generation Complement Therapeutics Market: Distribution by Target Disease Indication, Therapeutic Area, Type of Molecule, Target Pathway, Type of Therapy, Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Next Generation Complement Therapeutics Market: Distribution by Target Disease Indication, Therapeutic Area, Type of Molecule, Target Pathway, Type of Therapy, Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • February 2022
  • 131 Pages
  • Global
From
Antibody Contract Manufacturing Market, 2020 - 2030 - Product Thumbnail Image

Antibody Contract Manufacturing Market, 2020 - 2030

  • Report
  • January 2020
  • 305 Pages
  • Global
From
Anti-Inflammatory Therapeutics Market by Therapeutic Class, Mechanism Of Action, Route Of Administration, Distribution Channel, Indication, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Anti-Inflammatory Therapeutics Market by Therapeutic Class, Mechanism Of Action, Route Of Administration, Distribution Channel, Indication, End User - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
Interferon Market by Indication (Cancer, Hepatitis C, Multiple Sclerosis), Interferon Type (Alpha, Beta, Gamma), Administration Route, End User, Product Type, Dosage Form - Global Forecast 2025-2030 - Product Thumbnail Image

Interferon Market by Indication (Cancer, Hepatitis C, Multiple Sclerosis), Interferon Type (Alpha, Beta, Gamma), Administration Route, End User, Product Type, Dosage Form - Global Forecast 2025-2030

  • Report
  • August 2025
  • 191 Pages
  • Global
From
Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective - Product Thumbnail Image

Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry Perspective

  • Report
  • August 2023
  • 267 Pages
  • Global
From
Head and Neck Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Head and Neck Cancer Therapeutics - Global Strategic Business Report

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Cancer Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Immunotherapy - Global Strategic Business Report

  • Report
  • August 2025
  • 291 Pages
  • Global
From
Urothelial Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Urothelial Cancer Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 126 Pages
  • Global
From
Tumor Necrosis Factor Inhibitor Drugs - Global Strategic Business Report - Product Thumbnail Image

Tumor Necrosis Factor Inhibitor Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 291 Pages
  • Global
From
Retinoblastoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Retinoblastoma Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 279 Pages
  • Global
From
Loading Indicator